Unexplored therapeutic opportunities in the human genome

Oprea, Tudor I., Bologa, Cristian G., Brunak, Søren, Campbell, Allen, Gan, Gregory N., Gaulton, Anna, Gomez, Shawn M., Guha, Rajarshi +33 more·2018·Nature Reviews Drug Discovery

DOI 10.1038/nrd.2018.14

Cited by (378)

Items 101–200 of 378

Reactive chemistry for covalent probe and therapeutic development
R. Justin Grams, Ku‐Lung Hsu · 2022 · Trends in Pharmacological Sciences
Using BERT to identify drug-target interactions from whole PubMed
Jehad Aldahdooh, Markus J. V. Vähä-Koskela, Jing Ping Tang, Ziaurrehman Tanoli · 2022 · BMC Bioinformatics
Structure-based view of the druggable genome
Jiayan Wang, Setayesh Yazdani, Ana Han, Matthieu Schapira · 2020 · Drug Discovery Today
The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
Santiago G. Lago, Sabine Bahn · 2022 · npj Genomic Medicine
Genetic deletion of gpr27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish
Anjali K. Nath, Junyan Ma, Zsu‐Zsu Chen, Zhuyun Li, Maria del Carmen Vitery, Michelle L. Kelley, Randall Theodore Peterson, Robert Edgardo Gerszten, Jing-Ruey Joanna Yeh · 2019 · The FASEB Journal
SmartGraph: a network pharmacology investigation platform
Gergely Zahoránszky-Köhalmi, Timothy K. Sheils, Tudor Ionel Oprea · 2020 · Journal of Cheminformatics
What are the current trends in G protein-coupled receptor targeted drug discovery?
Vicent Casadó, Verònica Casadó-Anguera · 2023 · Expert Opinion on Drug Discovery
Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes
Ogasawara, Daisuke, Konrad, David B., Tan, Zher Yin, Carey, Kimberly L., Luo, Jessica, Won, Sang Joon, Li, Haoxin, Carter, Trever R., DeMeester, Kristen E., Njomen, Evert et al. · 2024 · Cell Chemical Biology
Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics
George S. Biggs, Emma E. Cawood, Aini Vuorinen, William J. McCarthy, Harry Wilders, Ioannis G. Riziotis, Antonie J. van der Zouwen, Jonathan Pettinger, Luke Nightingale, Peiling Chen et al. · 2025 · Nature Communications
Epigenetic Target Fishing with Accurate Machine Learning Models
Norberto Sánchez‐Cruz, José L. Medina‐Franco · 2021 · Journal of Medicinal Chemistry
Generative AI lacks the human creativity to achieve scientific discovery from scratch
Amy Wenxuan Ding, Shibo Li · 2025 · Scientific Reports
High Fidelity of Mouse Models Mimicking Human Genetic Skeletal Disorders
Robert Brommage, Claes Ohlsson · 2020 · Frontiers in Endocrinology
CRISPR Meets Zebrafish: Accelerating the Discovery of New Therapeutic Targets
Davide Rubbini, Carles Cornet, Javier Terriente, Vincenzo Di Donato · 2020 · SLAS DISCOVERY
Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses
Andrés López‐Cortés, Alejandro Cabrera‐Andrade, Gabriela Echeverría‐Garcés, Paulina Echeverría-Espinoza, Micaela Pineda-Albán, Nicole Elsitdie, José Bueno‐Miño, Carlos Manuel Cruz Segundo, Julián Dorado, Alejandro Pazos et al. · 2024 · Scientific Reports
A comprehensive review of emerging approaches in machine learning for de novo PROTAC design
Yossra Gharbi, Rocío Mercado · 2024 · Digital Discovery
Development of a CDK10/CycM in vitro Kinase Screening Assay and Identification of First Small-Molecule Inhibitors
Thomas Robert, Jared Lee Johnson, Roxane Guichaoua, Tomer M. Yaron, Stéphane Bach, Lewis C. Cantley, Pierre Colas · 2020 · Frontiers in Chemistry
CORUM in 2024: protein complexes as drug targets
Ralph Steinkamp, George Tsitsiridis, Barbara Brauner, Corinna Montrone, Gisela Fobo, Goar Frishman, Sorin I. Avram, Tudor Ionel Oprea, Andreas Ruepp · 2024 · Nucleic Acids Research
Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers
Siddesh Southekal, Nitish K. Mishra, Chittibabu Guda · 2021 · Cancers
Progress towards completing the mutant mouse null resource
Kevin A. Peterson, Stephen A. Murray · 2021 · Mammalian Genome
Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics
Max Lam, Chia‐Yen Chen, Tian Ge, Yan Xia, David W. Hill, Joey W. Trampush, Jin Yu, Emma Knowles, Gail Davies, Eli A. Stahl et al. · 2021 · Neuropsychopharmacology
Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Surovi Saikia, Manobjyoti Bordoloi, Rajeev Sarmah · 2018 · Current Drug Targets
The Playbooks of Medicinal Chemistry Design Moves
Mahendra Awale, Jérôme Hert, Laura Guasch, Sereina Riniker, Christian Krämer · 2021 · Journal of Chemical Information and Modeling
Multiscale modelling of drug mechanism and safety
Jitao David Zhang, Lisa Sach-Peltason, Christian Krämer, Ken Wang, Martin Ebeling · 2019 · Drug Discovery Today
Multi-omics analyses of cognitive traits and psychiatric disorders highlight brain-dependent mechanisms
Roxanna Korologou‐Linden, Genevieve M Leyden, Caroline Laura Relton, Rebecca Claire Richmond, Tom G. Richardson · 2021 · Human Molecular Genetics
An update regarding the role of WNK kinases in cancer
Mengxi Xiu, Li Li, Yandong Li, Yong Gao · 2022 · Cell Death and Disease
Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: A preliminary computational analysis of the COSMIC Cancer Gene Census
Sony Malhotra, Ali F. Alsulami, Yang Heiyun, Bernardo Ochoa, Harry C. Jubb, Simon Andrew Forbes, Tom L. Blundell · 2019 · PLoS ONE
The dark genome and pleiotropy: challenges for precision medicine
Steve D. M. Brown, Heena Vanmalibhai Lad · 2019 · Mammalian Genome
Small-Molecule Ligands Targeting Lysosome-Shuttling Receptors and the Emerging Landscape of Lysosome-Targeting Chimeras
Jingjing Yang, Heping Zhu · 2025 · Journal of Medicinal Chemistry
Meta-Research: Understudied genes are lost in a leaky pipeline between genome-wide assays and reporting of results
Richardson, Reese, Tejedor Navarro, Heliodoro, Amaral, Luis A Nunes, Stoeger, Thomas · 2024 · eLife
AI meets physics in computational structure-based drug discovery for GPCRs
Mayako Michino, Jérémie Vendôme, Irina Kufareva · 2025 · npj Drug Discovery.
Target identification and assessment in the era of AI
Frank W. Pun, Dmitriy I. Podolskiy, Evgeny Izumchenko, Andrew A. Mortlock, Tudor Ionel Oprea, Morten Scheibye‐Knudsen, Kristen Fortney, Eric K. Morgen, Feng Ren, Alex A. Zhavoronkov · 2026 · Nature Reviews Drug Discovery
GPCR-BERT: Interpreting Sequential Design of G Protein-Coupled Receptors Using Protein Language Models
Seongwon Kim, Parisa Mollaei, Akshay Antony, Rishikesh Magar, Amir Barati Farimani · 2024 · Journal of Chemical Information and Modeling
Metabolic mapping of the human solute carrier superfamily
Tabea Wiedmer, Shao Thing Teoh, Eirini Christodoulaki, Gernot Wolf, Chengzhe Tian, Vitaly Sedlyarov, Abigail P Jarret, Philipp Leippe, Fabian Frommelt, Álvaro Inglés‐Prieto et al. · 2025 · Molecular Systems Biology
AiGPro: a multi-tasks model for profiling of GPCRs for agonist and antagonist
Rahul Brahma, Sunghyun Moon, Jae-Min Shin, Kwang‐Hwi Cho · 2025 · Journal of Cheminformatics
A Computational Exploration of the Molecular Network Associated to Neuroinflammation in Alzheimer’s Disease
Fatima El Idrissi, Bernard Gressier, David Devos, Karim Bélarbi · 2021 · Frontiers in Pharmacology
Antibody Therapies Targeting Complex Membrane Proteins
Georgina To’a Salazar, Ziyi Huang, Ningyan Zhang, Xueguang Zhang, Zhiqiang An · 2021 · Engineering
Computer-Aided Discovery of Small Molecule Inhibitors of Transcriptional Activity of TLX (NR2E1) Nuclear Receptor
Evgenia V. Dueva, Kriti Singh, Anastasia Kalyta, Eric Leblanc, Paul S. Rennie, Artem R Cherkasov · 2018 · Molecules
Mapping biologically active chemical space to accelerate drug discovery
Gurusingham Sitta Sittampalam, Dobrila D. Rudnicki, Danilo A. Tagle, Anton M. Simeonov, Christopher P. Austin · 2018 · Nature Reviews Drug Discovery
Designing drugs when there is low data availability: one-shot learning and other approaches to face the issues of a long-term concern
Gabriel Corrêa Veríssimo, Mateus Sá Magalhães Serafim, Thales Kronenberger, Rafaela Salgado Ferreira, Káthia M. Honório, Vinícius Gonçalves Maltarollo · 2022 · Expert Opinion on Drug Discovery
An Approach for the Real-Time Quantification of Cytosolic Protein–Protein Interactions in Living Cells
Ilaria Incaviglia, Andreas Frutiger, Yves Blickenstorfer · 2021 · ACS Sensors
Mass spectrometry informs the structure and dynamics of membrane proteins involved in lipid and drug transport
Jani Reddy Bolla, Francesco Fiorentino, Carol V. Robinson · 2021 · Current Opinion in Structural Biology
Targeting Orphan G Protein-Coupled Receptor 17 with T0 Ligand Impairs Glioblastoma Growth
Phuong Doan, Phung Nguyen, Akshaya Murugesan, Kumar Subramanian, Konda Mani Saravanan, Kalimuthu Vignesh, Bobin George Abraham, Brett William Stringer, Balamuthu Kadalmani, Olli P. Yli-Harja et al. · 2021 · Cancers
About the dark corners in the gene function space of Escherichia coli remaining without illumination by scientific literature
Erwin Tantoso, Birgit Eisenhaber, Swati Sinha, Lars Juhl Jensen, Frank Eisenhaber · 2023 · Biology Direct
New Targets and Emergent Therapies for Osteoporosis
Robert Brommage · 2019 · Handbook of experimental pharmacology
Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function
William R. Reay, Sahar I El Shair, Michael P. Geaghan, Carlos Riveros, Elizabeth G. Holliday, Mark McEvoy, Stephen John Hancock, Roseanne Peel, Rodney John Scott, John Attia et al. · 2021 · eLife
NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells
Margarite D. Matossian, Steven G. Elliott, T. Van Hoang et al. · 2021 · Breast Cancer Research and Treatment
Molecular and pharmacological characterization of biogenic amine receptors from the diamondback moth, Plutella xylostella
Tiansheng Liu, Xue Zhan, Yuan Yu · 2021 · Pest Management Science
Accelerating SLC Transporter Research: Streamlining Knowledge and Validated Tools
Tabea Wiedmer, Álvaro Inglés‐Prieto, Ulrich Goldmann, Claire M. Steppan, Giulio Superti‐Furga, the RESOLUTE, REsolution consortia · 2022 · Clinical Pharmacology & Therapeutics
Protein network exploration prioritizes targets for modulating neuroinflammation in Parkinson’s disease
Marie-Amandine Bonte, Fatima El Idrissi, Bernard Gressier, David Devos, Karim Bélarbi · 2021 · International Immunopharmacology
Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia
Shumaila Sayyab, Anders Lundmark, Malin Larsson et al. · 2021 · Scientific Reports
Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs
Mariafrancesca Scalise, Lara Console, Michele Galluccio, Lorena Pochini, Annamaria Tonazzi, Nicola Giangregorio, Cesare Indiveri · 2019 · SLAS DISCOVERY
‘Design, synthesis, and strategic use of small chemical probes toward identification of novel targets for drug development’
Maria Paola Castaldi, J. Adam Hendricks, Andrew X. Zhang · 2020 · Current Opinion in Chemical Biology
In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation
Yunan Zheng, Anamika Singh, Zeqi Niu, Violeta L. Marin, Jonathon Young, Paul L. Richardson, Marcus L. Hemshorn, Richard B. Cooley, P. Andrew Karplus, Kedar Puvar et al. · 2025 · Journal of the American Chemical Society
ZMAT2 in Humans and Other Primates: A Highly Conserved and Understudied Gene
Kabita Baral, Peter S. Rotwein · 2020 · Evolutionary Bioinformatics
In vivo synthetic chemistry of proteolysis targeting chimeras (PROTACs)
Shusuke Tomoshige, Minoru Ishikawa · 2021 · Bioorganic & Medicinal Chemistry
G Protein-coupled Receptor (GPCR) Reconstitution and Labeling for Solution Nuclear Magnetic Resonance (NMR) Studies of the Structural Basis of Transmembrane Signaling
Haoyi Ge, Huixia Wang, Benxun Pan, Dandan Feng, Canyong Guo, Lingyun Yang, Dongsheng Liu, Kurt Wüthrich · 2022 · Molecules
Exploring DrugCentral: from molecular structures to clinical effects
Liliana Halip, Sorin I. Avram, Ramona F. Curpan · 2023 · Journal of Computer-Aided Molecular Design
Overview of the Knowledge Management Center for Illuminating the Druggable Genome
Tudor Ionel Oprea, Cristian Bologa, Jayme Holmes, Stephen L. Mathias, Vincent T. Metzger, Anna Waller, Jeremy J. Yang, Andrew R. Leach, Lars Juhl Jensen, Keith J. Kelleher et al. · 2024 · Drug Discovery Today
An Approach for the Real-Time Quantification of Cytosolic Protein-Protein Interactions in Living Cells
Ilaria Incaviglia, Andreas Frutiger, Yves Blickenstorfer · 2021 · Zurich Open Repository and Archive (University of Zurich)
Transcriptome-Guided Identification of Drugs for Repurposing to Treat Age-Related Hearing Loss
Nick M. A. Schubert, Marcel van Tuinen, Sonja J. Pyott · 2022 · Biomolecules
Integrating Large-Scale Protein Structure Prediction into Human Genetics Research
Miguel Correa Marrero, Jürgen Jänes, Delora Baptista, Pedro Beltrão · 2024 · Annual Review of Genomics and Human Genetics
Far away from the lamppost
Tudor Ionel Oprea, Lily Yeh Jan, Gary L. Johnson, Bryan L. Roth, Avi Ma’ayan, Stephan C. Schürer, Brian K. Shoichet, Larry A. Sklar, Michael T. McManus · 2018 · PLoS Biology
Prioritizing Pain-Associated Targets with Machine Learning
Minji Jeon, Kathleen M. Jagodnik, Eryk Kropiwnicki, Daniel J. Stein, Avi Ma’ayan · 2021 · Biochemistry
Characterization of the Binding of Small Molecules to Intrinsically Disordered Proteins
Veselin S. Dobrev, Lisette M. Fred, Kaitlyn P. Gerhart, Steven J. Metallo · 2018 · Methods in enzymology on CD-ROM/Methods in enzymology
Drug Design of “Undruggable” Targets
Jie Wang, Shiliang Li, Honglin Li · 2019 · Chinese Journal of Chemistry
Organic Composomes as Supramolecular Aptamers
Tracey N. Bell, Keke Feng, Gabriel Calvin, David H. Van Winkle, Steven Lenhert · 2020 · ACS Omega
The characteristics of early-stage research into human genes are substantially different from subsequent research
Thomas Stoeger, Luı́s A. Nunes Amaral · 2022 · PLoS Biology
e-TSN: an interactive visual exploration platform for target–disease knowledge mapping from literature
Ziyan Feng, Zihao Shen, Honglin Li, Shiliang Li · 2022 · Briefings in Bioinformatics
Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily
Daniela Digles, Álvaro Inglés‐Prieto, Vojtech Dvorak, Tamara A. M. Mocking, Ulrich Goldmann, Andrea Garofoli, Evert J. Homan, Alberto di Silvio, Lucia Azzollini, Francesca Sassone et al. · 2024 · Frontiers in Pharmacology
Machine Learning Prediction of On/Off Target-driven Clinical Adverse Events
Albert Cao, Luchen Zhang, Yingzi Bu, Duxin Sun · 2024 · Pharmaceutical Research
Orphan G-Protein Coupled Receptor GPRC5B Is Critical for Lymphatic Development
Wenjing Xu, Nathan Nelson-Maney, László Bálint, Hyouk-Bum Kwon, Reema B. Davis, Danica Dy, James M. Dunleavey, Brad St. Croix, Kathleen M. Caron · 2022 · International Journal of Molecular Sciences
Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands
Johannes Freudenberg, Ian Dunham, Philippe Sanséau, Deepak K. Rajpal · 2018 · BMC Bioinformatics
Development of a chemogenomics library for phenotypic screening
Bryan Dafniet, Natacha Cerisier, Batiste Boezio, Anaelle Clary, Pierre Ducrot, Thierry Dorval, Arnaud Gohier, David Brown, Karine Audouze, Olivier Taboureau · 2021 · Journal of Cheminformatics
Semi-supervised meta-learning elucidates understudied molecular interactions
You Wu, Li Xie, Yang Liu, Lei Xie · 2024 · Communications Biology
Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs
Georg E. Winter · 2024 · ACS Chemical Biology
It all clicks together: In silico drug discovery becoming mainstream
Antonina L. Nazarova, Vsevolod Katritch · 2022 · Clinical and Translational Medicine
Illuminating the druggable genome through patent bioactivity data
María Paula Magariños, Anna Gaulton, Eloy Félix, Tevfik Kizilören, Ricardo Arcila, Tudor Ionel Oprea, Andrew R. Leach · 2023 · PeerJ
Data-Driven Exploration of Selectivity and Off-Target Activities of Designated Chemical Probes
Filip N. Miljković, Jürgen Bajorath · 2018 · Molecules
Drug Repositioning: New Opportunities for Older Drugs
Vladimir Poroikov, Dmitry S. Druzhilovskiy · 2019 · Elsevier eBooks
PRESCOTT: a population aware, epistatic, and structural model accurately predicts missense effects
Tekpinar, Mustafa, David, Laurent, Henry, Thomas, Carbone, Alessandra · 2025 · Genome Biology
In situ construction of intracellular supramolecular assemblies as an alternative strategy for protein degradation
Xiaoqian Hu, Qingxin Yao, Xiaobo Wu, Jiali Chen, Ruijia Zhang, Yan Zhao, Yuan Gao · 2025 · Nature Communications
Small-molecule inhibition of the archetypal UbiB protein COQ8
Nathan H. Murray, Adam Lewis, Christopher R. M. Asquith, Juan Pablo Rincon Pabon, Zixiang Fang, Naomi Ptak, Robert Smith, James D. Vasta, Chad Zimprich, Cesear R. Corona et al. · 2022 · Nature Chemical Biology
HetIG-PreDiG: A Heterogeneous Integrated Graph Model for Predicting Human Disease Genes based on gene expression
Kathleen M. Jagodnik, Yael Shvili, Alon Bartal · 2023 · PLoS ONE
A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research
Gergely Zahoránszky-Köhalmi, Vishal B. Siramshetty, Praveen Kumar, Manideep Gurumurthy, Busola Grillo, Biju Mathew, Dimitrios Metaxatos, Mark Backus, Tim Mierzwa, Reid Simon et al. · 2022 · Journal of Chemical Information and Modeling
Probing the orphan receptors: Tools and directions
Luca Franchini, Cesare Orlandi · 2022 · Progress in molecular biology and translational science
Crowdsourced mapping extends the target space of kinase inhibitors
Anna Cichońska, Balaguru Ravikumar, Robert J. Allaway, Sung‐Joon Park, Fang Wan, Olexandr Isayev, Shuya Li, Mike J. Mason, Andrew E. Lamb, Ziaurrehman Tanoli et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Emerging opportunities for intact and native protein analysis using chemical proteomics
Alexis N. Edwards, Ku‐Lung Hsu · 2024 · Analytica Chimica Acta
Enantioselective protein affinity selection mass spectrometry (E-ASMS)
Xiaoyun Wang, Jianxian Sun, Shabbir Ahmad, Diwen Yang, Fengling Li, U Hang Chan, Hong Zeng, Conrad Veranso Simoben, Stuart R. Green, Madhushika Silva et al. · 2025 · Nature Communications
Transcriptome‐wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer
Elisa Mariella, Gaia Grasso, Martina Miotto, Kristi Buzo, Nicole Megan Reilly, Pietro Andrei, Pietro Paolo Vitiello, Giovanni Crisafulli, Sabrina Arena, Giuseppe Rospo et al. · 2024 · Molecular Oncology
Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3
Martin Schröder, P. Filippakopoulos, Martin P. Schwalm, Carla Alamillo‐Ferrer, David H. Drewry, Stefan Knapp, A. Chaikuad · 2020 · International Journal of Molecular Sciences
Pleiotropy data resource as a primer for investigating co-morbidities/multi-morbidities and their role in disease
Violeta Muñoz‐Fuentes, Hamed Haselimashhadi, Luís Santos, Henrik Westerberg, Helen Parkinson, Jeremy Mason · 2021 · Mammalian Genome
Diversity & tractability revisited in collaborative small molecule phenotypic screening library design
Brian R. Lahue, Meir Glick, Matthew Tudor, Scott Arne Johnson, Janet Diratsouian, Mary Jo Wildey, Marybeth S. Burton, Robert Mazzola, Anne Mai Wassermann · 2019 · Bioorganic & Medicinal Chemistry
Reverse Phase Protein Arrays in cancer stem cells
Michele Signore, Valeria Manganelli · 2022 · Methods in cell biology
Encapsulation of HaCaT Secretome for Enhanced Wound Healing Capacity on Human Dermal Fibroblasts
Nudjanad Heebkaew, Wilasinee Promjantuek, Nipha Chaicharoenaudomrung, Ruchee Phonchai, Phongsakorn Kunhorm, Natchadaporn Sorraksa, Parinya Noisa · 2023 · Molecular Biotechnology
Shedding light on the dark genome: Insights into the genetic, CRISPR-based, and pharmacological dependencies of human cancers and disease aggressiveness
Doris Kafita, Panji Nkhoma, Kevin Dzobo, Musalula Sinkala · 2023 · PLoS ONE
Synthesis and Analysis of Natural‐Product‐Like Macrocycles by Tandem Oxidation/Oxa‐Conjugate Addition Reactions
Hyunji Lee, Kayla Sylvester, Emily Rose Derbyshire · 2019 · Chemistry - A European Journal
Improving the Utility of the Tox21 Dataset by Deep Metadata Annotations and Constructing Reusable Benchmarked Chemical Reference Signatures
Daniel J. Cooper, Stephan C. Schürer · 2019 · Molecules
Complete Topological Mapping of a Cellular Protein Interactome Reveals Bow-Tie Motifs as Ubiquitous Connectors of Protein Complexes
Kristoffer Niss, Cristina Gómez‐Casado, Jessica Xin Hjaltelin, Thorsten Joeris, William W. Agace, Kirstine Belling, Søren Brunak · 2020 · Cell Reports
The Bitter Taste Receptor TAS2R14 as a Drug Target
Lukas A. W. Waterloo, Stefan Löber, Peter Gmeiner · 2022 · CHIMIA International Journal for Chemistry
Autophagy dark genes: Can we find them with machine learning?
Ranjbar, Mohsen, Yang, Jeremy J., Kumar, Praveen, Byrd, Daniel R., Bearer, Elaine L., Oprea, Tudor I. · 2023 · Natural Sciences